HLA-DQA1/B1 alleles as putative susceptibility markers in congenital toxoplasmosis

References

• Hill DE, Chirukandoth S, Dubey JP. Biology and epidemiology of Toxoplasma gondii in man and animals. Anim Health Res Rev 2005; 6:41-61; PMID:16164008; http://dx.doi.org/10.1079/AHR2005100
   PubMedGoogle Scholar
• Dubey JP, Lago EG, Gennari SM, Su C, Jones JL. Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology. Parasitology 2012; 139:1375-424; PMID:22776427; http://dx.doi.org/10.1017/S0031182012000765
   PubMed Web of Science ®Google Scholar
• Robert-Gangneux F. It is not only the cat that did it: How to prevent and treat congenital toxoplasmosis. J Infect 2014; 68:S125-33; PMID:24119928; http://dx.doi.org/10.1016/j.jinf.2013.09.023
   PubMed Web of Science ®Google Scholar
• Howe DK, Sibley LD. Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J Infect Dis 1995; 172:1561-6; PMID:7594717; http://dx.doi.org/10.1093/infdis/172.6.1561
   PubMed Web of Science ®Google Scholar
• Costa JM, Pautas C, Ernault P, Foulet F, Cordonnier C, Bretagne S. Real-time PCR for diagnosis and follow-up of Toxoplasma reactivation after allogeneic stem cell transplantation using fluorescence resonance energy transfer hybridization probes. J Clin Microbiol 2000; 38:2929-32; PMID:10921953
   PubMed Web of Science ®Google Scholar
• Romand S, Chosson M, Franck J, Wallon M, Kieffer F, Kaiser K, Dumon H, Peyron F, Thulliez P, Picot S. Usefulness of quantitative polymerase chain reaction in amniotic fluid as early prognostic marker of fetal infection with Toxoplasma gondii. Am J Obstet Gynecol 2004; 190:797-802
   PubMed Web of Science ®Google Scholar
• Tan TG, Mui E, Cong H, Witola WH, Montpetit A, Muench SP, Sidney J, Alexander J, Sette A, Grigg ME, et al. Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans. Vaccine 2010; 28:3977-89; PMID:20347630; http://dx.doi.org/10.1016/j.vaccine.2010.03.028
   PubMed Web of Science ®Google Scholar
• Kotb M, Norrby-Teglund A, McGeer A, El-Sherbini H, Dorak MT, Khurshid A, Green K, Peeples J, Wade J, Thomson G, et al. An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med 2002; 8:1398-404; PMID:12436116; http://dx.doi.org/10.1038/nm1202-800
   PubMed Web of Science ®Google Scholar
• Trowsdale J, Knight JC. Major histocompatibility complex genomics and human disease. Annu Rev Genomics Human Genet 2013; 14:301-23; http://dx.doi.org/10.1146/annurev-genom-091212-153455
   PubMed Web of Science ®Google Scholar
• Klein J, Sato A. The HLA system. First of two parts. N Engl J Med 2000; 343:702-9; PMID:10974135; http://dx.doi.org/10.1056/NEJM200009073431006
   PubMed Web of Science ®Google Scholar
• Klein J, Sato A. The HLA system. Second of two parts. N Engl J Med 2000; 343:782-6; PMID:10984567; http://dx.doi.org/10.1056/NEJM200009143431106
   PubMed Web of Science ®Google Scholar
• Thorsby E. A short history of HLA. Tissue Antigens 2009; 74:101-16; PMID:19523022; http://dx.doi.org/10.1111/j.1399-0039.2009.01291.x
   PubMed Web of Science ®Google Scholar
• Okay TS, Yamamoto L, Oliveira LC, Manuli ER, de Andrade HF, Jr, Del Negro GM. Significant performance variation among PCR systems in diagnosing congenital toxoplasmosis in São Paulo, Brazil: analysis of 467 amniotic fluid samples. Clinics (Sao Paulo) 2009; 64:171-6; PMID:19330240; http://dx.doi.org/10.1590/S1807-59322009000300004
   PubMed Web of Science ®Google Scholar
• Teixeira LE, Kanunfre KA, Shimokawa PT, Targa LS, Rodrigues JC, Domingues W, Yamamoto L, Okay TS. The performance of four molecular methods for the laboratory diagnosis of congenital toxoplasmosis in amniotic fluid samples. Rev Soc Bras Med Trop 2013; 46:584-8; PMID:24409481; http://dx.doi.org/10.1590/0037-8682-0095-2013
   PubMed Web of Science ®Google Scholar
• Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39:225-35; PMID:1357775; http://dx.doi.org/10.1111/j.1399-0039.1992.tb01940.x
   PubMed Web of Science ®Google Scholar
• Mullighan CG, Bunce M, Welsh KI. High-resolution HLA-DQB1 typing using the polymerase chain reaction and sequence-specific primers. Tissue Antigens 1997; 50: 688-92; PMID:9458131; http://dx.doi.org/10.1111/j.1399-0039.1997.tb02936.x
   PubMed Web of Science ®Google Scholar
• Pereira AP, Dias MA, Bastos MH, da Gama SG, Leal Mdo C. Determining gestational age for public health care users in Brazil: comparison of methods and algorithm creation. BMC Res Notes 2013; 6:60; PMID:23402277; http://dx.doi.org/10.1186/1756-0500-6-60
   PubMedGoogle Scholar
• Montoya JG, Remington JS. Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis 2008; 47:554-66; PMID:18624630; http://dx.doi.org/10.1086/590149
   PubMed Web of Science ®Google Scholar
• Sterkers Y, Pratlong F, Albaba S, Loubersac J, Picot MC, Pretet V, Issert E, Boulot P, Bastien P. Novel interpretation of molecular diagnosis of congenital toxoplasmosis according to gestational age at the time of maternal infection. J Clin Microbiol 2012; 50:3944-51; PMID:23035201; http://dx.doi.org/10.1128/JCM.00918-12
   PubMed Web of Science ®Google Scholar
• Wallon M, Franck J, Thulliez P, Huissoud C, Peyron F, Garcia-Meric P, Kieffer F. Accuracy of real-time polymerase chain reaction for Toxoplasma gondii in amniotic fluid. Obstet Gynecol 2010; 115:727-33; PMID:20308831; http://dx.doi.org/10.1097/AOG.0b013e3181d57b09
   PubMed Web of Science ®Google Scholar
• Bessières MH, Berrebi A, Cassaing S, Fillaux J, Cambus JP, Berry A, Assouline C, Ayoubi JM, Magnaval JF. Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosis. Mem Inst Oswaldo Cruz 2009; 104:389-92; http://dx.doi.org/10.1590/S0074-02762009000200038
   PubMed Web of Science ®Google Scholar
• Morelle C, Varlet-Marie E, Brenier-Pinchart MP, Cassaing S, Pelloux H, Bastien P, Sterkers Y. Comparative assessment of a commercial kit and two laboratory-developed PCR assays for molecular diagnosis of congenital toxoplasmosis. J Clin Microbiol 2012; 50:3977-82; PMID:23035184; http://dx.doi.org/10.1128/JCM.01959-12
   PubMed Web of Science ®Google Scholar
• Prusa AR, Kasper DC, Pollak A, Olischar M, Gleiss A, Hayde M. Amniocentesis for the detection of congenital toxoplasmosis: results from the nationwide Austrian prenatal screening program. Clin Microbiol Infect 2015; 21:191.e1-8; PMID:25596783; http://dx.doi.org/10.1016/j.cmi.2014.09.018
   PubMedGoogle Scholar
• Sensini A. Toxoplasma gondii infection in pregnancy: opportunities and pitfalls of serological diagnosis. Clin Microbiol Infect 2006; 12:504-12; PMID:16700697; http://dx.doi.org/10.1111/j.1469-0691.2006.01444.x
   PubMed Web of Science ®Google Scholar
• Ladas ID, Rallatos CL, Kanaki CS, Damanakis AG, Zafirakis PK, Rallatos G. Presumed congenital ocular toxoplasmosis in two successive siblings. Ophthalmologica 1999; 213:320-2; PMID:10516521; http://dx.doi.org/10.1159/000027446
   PubMed Web of Science ®Google Scholar
• Silveira C, Ferreira R, Muccioli C, Nussenblatt R, Belfort R, Jr. Toxoplasmosis transmitted to a newborn from the mother infected 20 years earlier. Am J Ophthalmol 2003; 136:370-1; PMID:12888070; http://dx.doi.org/10.1016/S0002-9394(03)00191-0
   PubMed Web of Science ®Google Scholar
• Kodjikian L, Hoigne I, Adam O, Jacquier P, Aebi-Ochsner C, Aebi C, Garweg JG. Vertical transmission of toxoplasmosis from a chronically infected immunocompetent woman. Pediatr Infect Dis J 2004; 23:272-4; PMID:15014310; http://dx.doi.org/10.1097/01.inf.0000115949.12206.69
   PubMed Web of Science ®Google Scholar
• Gavinet MF, Robert F, Firtion G, Delouvrier E, Hennequin C, Maurin JR, Tourte-Schaefer C, Dupouy-Camet J. Congenital toxoplasmosis due to maternal reinfection during pregnancy. J Clin Microbiol 1997; 35:1276-7; PMID:9114425
   PubMed Web of Science ®Google Scholar
• Valdès V, Legagneur H, Watrin V, Paris L, Hascoët JM. Congenital toxoplasmosis due to maternal reinfection during pregnancy. Arch Pediatr 2011; 18:761-3; http://dx.doi.org/10.1016/j.arcped.2011.04.011
   PubMed Web of Science ®Google Scholar
• Lago EG, Oliveira AP, Bender AL. Presence and duration of anti-Toxoplasma gondii immunoglobulin M in infants with congenital toxoplasmosis. J Pediatr (Rio J) 2014; 90:363-9;PMID:24530469; http://dx.doi.org/10.1016/j.jped.2013.12.006
   PubMed Web of Science ®Google Scholar
• Wallon M, Cozon G, Ecochard R, Lewin P, Peyron F. Serological rebound in congenital toxoplasmosis: long-term follow-up of 133 children. Eur J Pediatr 2001; 160:534-40; PMID:11585075; http://dx.doi.org/10.1007/s004310100805
   PubMed Web of Science ®Google Scholar
• Villena I, Aubert D, Leroux B, Dupouy D, Talmud M, Chemla C, Trenque T, Schmit G, Quereux C, Guenounou M, et al. Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group. Scand J Infect Dis 1998; 30:295-300; PMID:9790140; http://dx.doi.org/10.1080/00365549850160963
   PubMedGoogle Scholar
• Jaisson-Hot I, Wallon M, al Kurdi M, Thulliez P, Kahi S, Cozon G, Peyron F. Congenital toxoplasmosis. Transitory negative serology. Presse Med 2001; 30:1001-4; PMID:11433684
   PubMed Web of Science ®Google Scholar
• Bidgoli S, Koch P, Caspers L. Toxoplasmic chorioretinitis: positive PCR on vitreous with negative serology for Toxoplasma gondii. J Fr Ophtalmol 2011; 34:384.e1-5; PMID:21492958; http://dx.doi.org/10.1016/j.jfo.2011.01.015
   PubMedGoogle Scholar
• Meenken C, Rothova A, de Waal LP, van der Horst AR, Mesman BJ, Kijlstra A. HLA typing in congenital toxoplasmosis. Br J Ophthalmol 1995; 79:494-7;PMID:7612565; http://dx.doi.org/10.1136/bjo.79.5.494
   PubMed Web of Science ®Google Scholar
• Mack DG, Johnson JJ, Roberts F, Roberts CW, Estes RG, David C, Grumet FC, McLeod R. HLA-class II genes modify outcome of Toxoplasma gondii infection. Int J Parasitol 1999; 29:1351-8; PMID:10579423; http://dx.doi.org/10.1016/S0020-7519(99)00152-6
   PubMed Web of Science ®Google Scholar
• Habegger de Sorrentino A, López R, Motta P, Marinic K, Sorrentino A, Iliovich E, Rubio AE, Quarleri J, Salomón H. HLA class II involvement in HIV-associated toxoplasmic encephalitis development. Clin Immunol 2005; 115:133-7; PMID:15885635; http://dx.doi.org/10.1016/j.clim.2005.01.003
   PubMed Web of Science ®Google Scholar